DNA Brands, Inc. (DNAX)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DNA Brands, Inc. (DNAX) with AI Score 48/100 (Weak). DNA Brands, Inc. operates in the competitive non-alcoholic beverage sector, offering energy drinks and advisory services. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 15, 2026DNA Brands, Inc. (DNAX) Consumer Business Overview
DNA Brands, Inc. is a small player in the energy drink market, offering various flavors to retailers, restaurants, bars, and clubs. The company also owns TokenTalk.io, an advisory firm for ICOs, diversifying its revenue streams but facing challenges common to OTC-listed companies with limited market capitalization.
Investment Thesis
Investing in DNA Brands, Inc. presents a high-risk, high-reward scenario. The company's small market capitalization and OTC listing introduce significant liquidity and transparency concerns. However, its 100% gross margin indicates potential profitability if sales volumes increase substantially. Growth catalysts include expanding distribution networks for its energy drinks and securing more advisory clients through TokenTalk.io. The company's beta of 1.37 suggests higher volatility compared to the broader market. Investors should carefully consider the risks associated with OTC-listed companies and the competitive nature of the energy drink market before investing.
Based on FMP financials and quantitative analysis
Key Highlights
- DNA Brands, Inc. operates with a market capitalization of $0.00B, indicating its micro-cap status.
- The company boasts a gross margin of 100.0%, suggesting efficient cost management in its production process.
- DNA Brands, Inc. has a beta of 1.37, implying higher volatility compared to the overall market.
- The company does not offer a dividend, which may deter income-seeking investors.
- DNA Brands, Inc. operates with a single employee, highlighting its lean operational structure.
Competitors & Peers
Strengths
- High gross margin (100%) indicates efficient cost management.
- Diversified revenue streams through energy drinks and ICO advisory services.
- Unique flavor profiles for energy drinks may attract niche markets.
- Lean operational structure with a small workforce.
Weaknesses
- Small market capitalization limits access to capital and resources.
- OTC listing increases risk and reduces investor confidence.
- Limited brand recognition compared to established competitors.
- Dependence on a single employee poses operational risks.
Catalysts
- Upcoming: Potential expansion of energy drink distribution network in Q3 2026.
- Ongoing: Marketing and branding initiatives to increase brand awareness.
- Ongoing: TokenTalk.io securing new advisory clients in the blockchain space.
Risks
- Potential: Intense competition from established energy drink brands could limit market share growth.
- Potential: Regulatory risks associated with ICOs and digital assets could impact TokenTalk.io.
- Ongoing: Limited financial disclosure and transparency due to OTC listing.
- Ongoing: Low trading volume and illiquidity could make it difficult to buy or sell shares.
- Ongoing: Dependence on a single employee poses operational risks.
Growth Opportunities
- Expansion of Distribution Network: DNA Brands, Inc. can grow by expanding its distribution network to reach more retailers, restaurants, bars, and clubs. The energy drink market is heavily reliant on widespread availability, and increasing the number of outlets carrying DNA Brands products could significantly boost sales. This could involve partnering with regional distributors or expanding the company's internal sales team. The timeline for this expansion could be within the next 1-2 years, with potential revenue increases of 10-15% annually.
- Increased Marketing and Branding Efforts: To compete effectively in the crowded energy drink market, DNA Brands, Inc. needs to invest in marketing and branding. This could involve social media campaigns, sponsorships, and collaborations with influencers. A stronger brand presence can attract new customers and increase brand loyalty. The timeline for implementing these marketing initiatives could be within the next 6-12 months, with potential for increased brand awareness and sales growth.
- Growth of TokenTalk.io Advisory Services: DNA Brands, Inc.'s TokenTalk.io advisory service offers a growth opportunity by capitalizing on the increasing interest in blockchain technology and digital assets. By providing advisory services to companies seeking to raise capital through ICOs, TokenTalk.io can generate revenue and diversify the company's income streams. The timeline for this growth depends on the regulatory environment and the overall health of the cryptocurrency market, but potential revenue could increase significantly within the next 2-3 years.
- Product Innovation and New Flavors: Introducing new and innovative flavors can attract new customers and retain existing ones. The energy drink market is constantly evolving, and consumers are always looking for new and exciting options. DNA Brands, Inc. can invest in research and development to create unique and appealing flavors that differentiate its products from competitors. The timeline for launching new flavors could be within the next 12-18 months, with potential for increased sales and market share.
- Strategic Partnerships and Acquisitions: DNA Brands, Inc. could explore strategic partnerships or acquisitions to expand its product portfolio, distribution network, or market reach. Partnering with other beverage companies or acquiring smaller brands could provide access to new markets and customers. The timeline for these partnerships or acquisitions is uncertain, but they could significantly accelerate the company's growth trajectory in the long term.
Opportunities
- Expansion of distribution network to increase market reach.
- Increased marketing and branding efforts to enhance brand awareness.
- Growth of TokenTalk.io advisory services in the blockchain space.
- Product innovation and development of new energy drink flavors.
Threats
- Intense competition from established energy drink brands.
- Regulatory risks associated with ICOs and digital assets.
- Fluctuations in commodity prices affecting ingredient costs.
- Changes in consumer preferences and health trends.
Competitive Advantages
- Brand recognition (limited but growing) in specific regional markets.
- Proprietary energy drink formulations and flavor profiles.
- TokenTalk.io provides a unique service offering in the niche market of ICO advisory.
About DNAX
DNA Brands, Inc., based in Fort Lauderdale, Florida, operates within the consumer defensive sector, specifically focusing on the non-alcoholic beverage industry. The company's primary business involves the development, marketing, and distribution of energy drinks in various flavors, including cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. These products are targeted towards retailers, restaurants, bars, and clubs. In addition to its beverage offerings, DNA Brands, Inc. owns TokenTalk.io, an advisory firm that assists companies in raising capital through Initial Coin Offerings (ICOs). This diversification attempts to capitalize on the evolving landscape of digital finance. The company's operations are primarily based in the United States. Given its OTC listing and small market capitalization, DNA Brands, Inc. faces challenges related to liquidity, visibility, and regulatory compliance. The company's ability to compete effectively in the crowded energy drink market and generate sustainable revenue from its advisory services will be critical to its long-term success.
What They Do
- Develops and markets energy drinks in various flavors.
- Offers cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon flavors.
- Targets retailers, restaurants, bars, and clubs as primary distribution channels.
- Owns and operates TokenTalk.io, an advisory firm for companies seeking ICO funding.
- Provides advisory services related to Initial Coin Offerings (ICOs).
- Focuses on the non-alcoholic beverage market segment.
Business Model
- Generates revenue through the sale of energy drinks to retailers, restaurants, bars, and clubs.
- Earns fees by providing advisory services to companies seeking to raise capital through ICOs via TokenTalk.io.
- Operates with a lean cost structure, reflected in its high gross margin.
Industry Context
DNA Brands, Inc. operates in the competitive non-alcoholic beverage industry, dominated by major players like Coca-Cola and PepsiCo, as well as energy drink giants like Monster and Red Bull. The industry is characterized by intense marketing and branding efforts to capture consumer attention. DNA Brands, Inc.'s smaller size and OTC listing present challenges in competing with these established brands. The energy drink segment continues to grow, driven by demand from younger consumers and those seeking functional beverages. The company's TokenTalk.io advisory service diversifies its revenue streams but also exposes it to the volatile cryptocurrency market.
Key Customers
- Retailers who stock and sell energy drinks to consumers.
- Restaurants, bars, and clubs that serve energy drinks to their patrons.
- Companies seeking advisory services for raising capital through Initial Coin Offerings (ICOs).
Financials
Chart & Info
DNA Brands, Inc. (DNAX) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Dec 3, 2019
-
Stocks That Broke Yearly Lows Tuesday Morning
· Aug 6, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DNAX.
Price Targets
Wall Street price target analysis for DNAX.
MoonshotScore
What does this score mean?
The MoonshotScore rates DNAX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Adrian Mckenzie Patasar
Managing Director
Adrian Mckenzie Patasar serves as the Managing Director of DNA Brands, Inc. Information regarding his detailed career history, educational background, and previous roles is not available. As the leader of the company, Patasar is responsible for overseeing the strategic direction, operational management, and financial performance of DNA Brands, Inc., including its energy drink business and TokenTalk.io advisory services.
Track Record: Due to limited information available, Adrian Mckenzie Patasar's specific achievements, strategic decisions, and company milestones under his leadership at DNA Brands, Inc. cannot be comprehensively assessed. The company's current market position and financial performance will be key indicators of his leadership effectiveness.
DNAX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by companies that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in OTC Other companies carries significant risks due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and illiquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Lack of regulatory oversight and investor protection.
- Verify the company's legal standing and registration.
- Attempt to obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the company's products and services and their market potential.
- Understand the company's business model and revenue streams.
- Evaluate the company's competitive landscape.
- Assess the risks associated with investing in an OTC-listed company.
- Operation of an actual business (energy drinks and ICO advisory).
- Registration as a legal entity.
- Existence of a website and online presence.
- Physical headquarters in Fort Lauderdale, Florida.
- Managing Director in place.
What Investors Ask About DNA Brands, Inc. (DNAX)
What does DNA Brands, Inc. do?
DNA Brands, Inc. operates in the consumer defensive sector, focusing on the non-alcoholic beverage industry. Its primary business is the development, marketing, and distribution of energy drinks in various flavors, targeting retailers, restaurants, bars, and clubs. Additionally, the company owns TokenTalk.io, an advisory firm that assists companies in raising capital through Initial Coin Offerings (ICOs). This diversification attempts to capitalize on the evolving landscape of digital finance, providing an alternative revenue stream alongside its core beverage business.
What do analysts say about DNAX stock?
As of 2026-03-15, there is no readily available analyst coverage or consensus on DNAX stock due to its OTC listing and small market capitalization. Key valuation metrics such as price-to-earnings ratio and price-to-sales ratio are not applicable given the company's current financial situation. Potential growth considerations include the expansion of its distribution network for energy drinks and the success of TokenTalk.io in securing new advisory clients. Investors should conduct their own thorough research before making any investment decisions.
What are the main risks for DNAX?
Investing in DNA Brands, Inc. carries significant risks due to its OTC listing and small market capitalization. These risks include limited financial disclosure and transparency, low trading volume and illiquidity, potential for price manipulation, and a higher risk of delisting or going out of business. Additionally, the company faces intense competition from established energy drink brands and regulatory risks associated with ICOs and digital assets. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for DNAX?
DNA Brands, Inc. (DNAX) currently holds an AI score of 48/100, indicating low score. Key strength: High gross margin (100%) indicates efficient cost management.. Primary risk to monitor: Potential: Intense competition from established energy drink brands could limit market share growth.. This is not financial advice.
How frequently does DNAX data refresh on this page?
DNAX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DNAX's recent stock price performance?
Recent price movement in DNA Brands, Inc. (DNAX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: High gross margin (100%) indicates efficient cost management.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DNAX overvalued or undervalued right now?
Determining whether DNA Brands, Inc. (DNAX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DNAX?
Before investing in DNA Brands, Inc. (DNAX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations due to its OTC listing.
- AI analysis pending for DNAX, further insights may be available in the future.